Cargando…
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition
Fatty acid binding protein (FABP4) inhibitors are of synthetic and therapeutic interest and ongoing clinical studies indicate that they may be a promise for the treatment of cancer, as well as other diseases. As part of a broader research effort to develop more effective FABP4 inhibitors, we sought...
Autores principales: | Crocetti, Letizia, Floresta, Giuseppe, Zagni, Chiara, Merugu, Divya, Mazzacuva, Francesca, de Oliveira Silva, Renan Rodrigues, Vergelli, Claudia, Giovannoni, Maria Paola, Cilibrizzi, Agostino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697826/ https://www.ncbi.nlm.nih.gov/pubmed/36355506 http://dx.doi.org/10.3390/ph15111335 |
Ejemplares similares
-
Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors
por: Tomarchio, Rosario, et al.
Publicado: (2023) -
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
por: Crocetti, Letizia, et al.
Publicado: (2022) -
PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes
por: Jin, Jian, et al.
Publicado: (2023) -
FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets
por: Floresta, Giuseppe, et al.
Publicado: (2018) -
Repurposing strategies on pyridazinone-based series by pharmacophore- and structure-driven screening
por: Floresta, Giuseppe, et al.
Publicado: (2020)